Skip to main content

Pathophysiology of Hypertension

  • Chapter
  • 230 Accesses

Abstract

Hypertension is diagnosed if a blood pressure greater than 150/95 mm Hg is obtained in both upper extremities in individuals less than 50 years of age on at least three office visits. It is an extremely common syndrome affecting over 23,000,000 people in the United States. The complications of hypertension are reversible if the syndrome is recognized early and treated adequately. Probably the single most significant study illustrating the effects of antihypertensive therapy in controlling the morbid events caused by hypertension was the V.A. Cooperative Study initiated in 1963. If individuals with diastolic blood pressures between 115 and 129 mm Hg were vigorously treated, morbid events (cerebrovascular accidents, coronary artery disease, congestive heart failure, or renal damage) were significantly reduced within 18 months of followup. For those individuals with diastolic blood pressures between 90 and 114 mm Hg, 36 months of followup were required to document a reduction in these morbid events. The results of the V.A. Cooperative Study clearly defined the beneficial effects of therapy in patients with severe (diastolic blood pressure greater than 115 mm Hg) hypertension.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Readings

General Articles

  • Brunner, H. R., and Gavras, H.: Vascular damage in hypertension. Hosp. Pract. 38:97–108, 1975.

    Google Scholar 

  • Davis, J. O.: The pathogenesis of chronic renovascular hypertension. Circ. Res. 40:439–443, 1977.

    Article  PubMed  CAS  Google Scholar 

  • Dluhy, R. G., Barli, S. L., Leung, F. K., Solomon, H. S., Moore, T. J., Hollenberg, N. K., and Williams, G. H.: Abnormal adrenal responsiveness and angiotensin II dependency in high renin hypertension, J. Clin. Invest. 64:1270–1276, 1979.

    Article  PubMed  CAS  Google Scholar 

  • Fröhlich, E. D.: Essential hypertension, pathophysiological mechanisms and therapy. Arch. Intern. Med. 137:772–775, 1977.

    Article  PubMed  Google Scholar 

  • Gavras, H., Brunner, H. R., Laragh, J. H., Sealey, J. E., Gavras, I., and Vukovich, R. A.: An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N. Engl. J. Med. 291:817–821, 1974.

    Article  PubMed  CAS  Google Scholar 

  • Helgeland, A.: Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am. J. Med. 69:725–732, 1980.

    Article  PubMed  CAS  Google Scholar 

  • Lilley, J. J., Golden, J., and Stone, R. A.: Adrenergic regulation of blood pressure in chronic renal failure. J.Clin. Invest. 57:1190–1200, 1976.

    Article  PubMed  CAS  Google Scholar 

  • McGrath, B. P., and Ledingham, J. G.: Renin, blood volume and response to saralasin in patients on chronic hemodialysis: evidence against volume and renin “dependent” hypertension. CM. Sci. Mol. Med. 54:305–312, 1978.

    CAS  Google Scholar 

  • Mills, I. H.: Kallikrein, kininogen and kinins in control of blood pressure. Nephron 23:61–71, 1979.

    Article  PubMed  CAS  Google Scholar 

  • Moser, M., Chairman: Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. A cooperative study. JAMA 237:255–262, 1977.

    Article  Google Scholar 

  • Sealey, J. E., Buhler, F. R., Laragh, J. H., and Vaughan, E. D.: The physiology of renin secretion in essential hypertension. Am. J. Med. 55:391–401, 1973.

    Article  PubMed  CAS  Google Scholar 

  • Veterans Administration Cooperative Study Group on Antihypertensive Agents. JAMA 213:1143–1149, 1970.

    Article  Google Scholar 

  • Veterans Administration Cooperative Study Group on Antihypertensive Agents. Circulation 45:991–1001, 1972.

    Article  Google Scholar 

  • Wisgerhof, M., and Brown, R. D.: Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension. J. Clin. Invest. 64:1456–1462, 1979.

    Google Scholar 

Textbooks

  • Kaplan, N. M.: Clinical Hypertension, Second edition. Williams & Wilkins Co., Baltimore, 1978.

    Google Scholar 

  • McMahon, F. G.: Management of Essential Hypertension, First edition. Futura Publishing Co., Mt. Kisco, New York, 1978.

    Google Scholar 

  • Williams, R. H. (ed.): Textbook of Endocrinology, Sixth edition. Saunders, Philadelphia, 1981.

    Google Scholar 

Review Articles

  • Birkenhager, W. H., and DeLeeuw, P. W.: Pathophysiological mechanisms in essential hypertension. Pharmacol. Ther. 8:297–319, 1980.

    Article  PubMed  CAS  Google Scholar 

  • Brody, M. J., Haywood, J. R., and Touw, K. B.: Neural mechanisms in hypertension. Annu. Rev. Physiol. 42:441–453, 1980.

    Article  PubMed  CAS  Google Scholar 

  • Brown, J. J., Fraser, R., Leckie, B., Lever, A. F., Morton, J. J., Podfield, P. L., Semple, P. F., and Robertson, J. S. Significance of renin and angiotensin in hypertension. Cardiovasc. Clin. 9:55–90, 1979.

    Google Scholar 

  • Giese, J.: The renin-angiotensin system and the pathogenesis of vascular disease in malignant hypertension. A review. Clin. Sei. Mol. Med. 51:19–24, 1976.

    Google Scholar 

  • Gonguly, A., and Weinberger, M. H.: Low renin hypertension: a current review of definitions and controversies. Am. Heart J. 98:642–652, 1979.

    Article  Google Scholar 

  • Hollenberg, N. K., and Williams, G. S.: Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system. Adv. Intern. Med. 25:327–361, 1980.

    PubMed  CAS  Google Scholar 

  • Kincaid-Smith, P.: Malignant hypertension; mechanisms and management. Pharmacol. Ther. 9:245–269, 1980.

    Article  PubMed  CAS  Google Scholar 

  • Page, L. B., Yager, H. M., and Sidd, J. J.: Drugs in the management of hypertension. Am. Heart J. Part 1–91:810–815, Part 11–92:114–118, and Part ni-92:252–259, 1976.

    Google Scholar 

  • Report of the Hypertension Task Force of the National Heart, Lung and Blood Institute. Current research and recommendations from the Subgroup on Local Hemodynamics. Hypertension 3:342–369, 1980.

    Google Scholar 

  • Simpson, F. O.: Principles of drug treatment for hypertension: indications for treatment and for selection of drugs. Pharmacol. Ther. 7:153–172, 1979.

    Article  PubMed  CAS  Google Scholar 

  • Tobian, L.: Sah and hypertension. Ann. N.Y. Acad. Sci. 189:178–202, 1978.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer Science+Business Media New York

About this chapter

Cite this chapter

Harter, H.R. (1983). Pathophysiology of Hypertension. In: Klahr, S. (eds) The Kidney and Body Fluids in Health and Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3524-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-3524-5_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-3526-9

  • Online ISBN: 978-1-4613-3524-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics